Capital International Sarl’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.57M Buy
40,000
+2,650
+7% +$371K 0.09% 143
2025
Q4
$4.58M Sell
37,350
-810
-2% -$98.4K 0.07% 156
2025
Q3
$4.24M Sell
38,160
-785
-2% -$89.2K 0.07% 154
2025
Q2
$4.32M Buy
38,945
+1,358
+4% +$145K 0.08% 153
2025
Q1
$4.21M Sell
37,587
-49,818
-57% -$5.14M 0.1% 144
2024
Q4
$8.07M Sell
87,405
-15,580
-15% -$1.4M 0.19% 112
2024
Q3
$8.63M Buy
102,985
+17,760
+21% +$1.36M 0.22% 103
2024
Q2
$5.85M Buy
85,225
+4,961
+6% +$331K 0.18% 115
2024
Q1
$5.88M Buy
80,264
+10,850
+16% +$834K 0.19% 116
2023
Q4
$5.62M Buy
69,414
+11,255
+19% +$876K 0.21% 110
2023
Q3
$4.36M Buy
58,159
+22,025
+61% +$1.69M 0.2% 119
2023
Q2
$2.78M Buy
+36,134
New +$2.88M 0.13% 154
2023
Q1
Sell
-6,865
Closed -$589K 231
2022
Q4
$589K Hold
6,865
0.04% 196
2022
Q3
$424K Sell
6,865
-576
-8% -$36.3K 0.03% 200
2022
Q2
$460K Sell
7,441
-4,811
-39% -$298K 0.04% 202
2022
Q1
$728K Sell
12,252
-62,812
-84% -$4.02M 0.04% 237
2021
Q4
$5.45M Sell
75,064
-4,853
-6% -$334K 0.26% 105
2021
Q3
$5.58M Sell
79,917
-3,047
-4% -$214K 0.49% 66
2021
Q2
$5.71M Buy
82,964
+4,642
+6% +$310K 0.49% 64
2021
Q1
$5.06M Sell
78,322
-9,613
-11% -$620K 0.48% 62
2020
Q4
$5.12M Buy
87,935
+402
+0.5% +$24.3K 0.54% 59
2020
Q3
$5.53M Sell
87,533
-22,046
-20% -$1.53M 0.68% 44
2020
Q2
$8.43M Buy
109,579
+19,543
+22% +$1.5M 1.12% 29
2020
Q1
$6.73M Buy
90,036
+49,929
+124% +$3.45M 1.23% 26
2019
Q4
$2.61M Buy
40,107
+782
+2% +$50.9K 0.4% 81
2019
Q3
$2.49M Buy
+39,325
New +$2.57M 0.43% 75
2019
Q1
Sell
-13,500
Closed -$844K 141
2018
Q4
$844K Sell
13,500
-9,300
-41% -$650K 0.1% 122
2018
Q3
$1.76M Sell
22,800
-10,100
-31% -$763K 0.17% 106
2018
Q2
$2.33M Sell
32,900
-700
-2% -$49.4K 0.24% 95
2018
Q1
$2.53M Sell
33,600
-100
-0.3% -$7.95K 0.24% 95
2017
Q4
$2.41M Sell
33,700
-8,150
-19% -$619K 0.23% 95
2017
Q3
$3.39M Buy
41,850
+6,410
+18% +$490K 0.28% 88
2017
Q2
$2.51M Hold
35,440
0.22% 95
2017
Q1
$2.41M Sell
35,440
-2,600
-7% -$183K 0.21% 100
2016
Q4
$2.72M Sell
38,040
-8,500
-18% -$632K 0.25% 97
2016
Q3
$3.68M Sell
46,540
-46,360
-50% -$3.77M 0.31% 90
2016
Q2
$7.75M Sell
92,900
-9,677
-9% -$859K 0.66% 50
2016
Q1
$9.42M Sell
102,577
-21,500
-17% -$1.94M 0.8% 38
2015
Q4
$12.6M Sell
124,077
-17,680
-12% -$1.84M 1.06% 31
2015
Q3
$13.9M Sell
141,757
-117,900
-45% -$13.1M 1.25% 24
2015
Q2
$30.4M Sell
259,657
-37,603
-13% -$4.11M 2.25% 8
2015
Q1
$29.2M Sell
297,260
-198,947
-40% -$20.2M 2.12% 9
2014
Q4
$46.8M Sell
496,207
-346,328
-41% -$35.8M 2.89% 4
2014
Q3
$89.7M Sell
842,535
-76,865
-8% -$7.53M 5.32% 1
2014
Q2
$76.2M Sell
919,400
-237,200
-21% -$18.5M 4.27% 1
2014
Q1
$82M Sell
1,156,600
-129,400
-10% -$10.1M 4.54% 1
2013
Q4
$96.6M Sell
1,286,000
-154,300
-11% -$10.7M 5.18% 1
2013
Q3
$90.5M Sell
1,440,300
-44,780
-3% -$2.68M 5.17% 1
2013
Q2
$76.1M Buy
+1,485,080
New +$77.4M 5.36% 1

Other funds holding GILD

Capital International Sarl's GILD Position: Q1 2026 in Review

Capital International Sarl increased its Gilead Sciences (GILD) stake by 7.1% in Q1 2026, buying an estimated $371K and bringing the position to 40,000 shares worth $5.57M. The position accounts for 0.09% of the portfolio, ranked #143.

Capital International Sarl first reported a position in GILD in Q2 2013 and has held it in 49 quarters since. The position peaked at $96.6M in Q4 2013. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Capital International Sarl held 40,000 shares of Gilead Sciences worth $5.57M as of Q1 2026.
  • Capital International Sarl bought 2,650 Gilead Sciences shares in Q1 2026, an estimated $371K.
  • Gilead Sciences made up 0.09% of Capital International Sarl's portfolio in Q1 2026, its #143 holding.
  • Capital International Sarl first reported a position in Gilead Sciences in Q2 2013 and has held it in 49 quarters since.
  • Capital International Sarl's Gilead Sciences position peaked at $96.6M in Q4 2013.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Capital International Sarl's 13F filing for Q1 2026, filed 13 May 2026.